Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:53 UTC |
---|
HMDB ID | HMDB0015185 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Novobiocin |
---|
Description | Novobiocin is only found in individuals that have used or taken this drug. It is an antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) [PubChem]Novobiocin is an aminocoumarin. Aminocoumarins are very potent inhibitors of bacterial DNA gyrase and work by inhibiting the GyrB subunit of the enzyme involved in energy tranduction. Novobiocin as well as the other aminocoumarin antibiotics act as competitive inhibitors of the ATPase reaction catalysed by GyrB. |
---|
Structure | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 |
---|
Synonyms | Value | Source |
---|
N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | ChEBI | Novobiocina | ChEBI | Novobiocine | ChEBI | Novobiocinum | ChEBI | N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-b-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | Generator | N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-β-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | Generator | Antibiotic pa-93 | HMDB | Crystallinic acid | HMDB | NOV | HMDB | Sodium, novobiocin | HMDB | Streptonivicin | HMDB | Calcium, novobiocin | HMDB | Monosodium salt novobiocin | HMDB | Novobiocin, monosodium salt | HMDB | Novobiocin calcium | HMDB | Novobiocin sodium | HMDB |
|
---|
Chemical Formula | C31H36N2O11 |
---|
Average Molecular Weight | 612.6243 |
---|
Monoisotopic Molecular Weight | 612.231910004 |
---|
IUPAC Name | (3R,4S,5R,6R)-5-hydroxy-6-({4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-8-methyl-2-oxo-2H-chromen-7-yl}oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate |
---|
Traditional Name | novobiocin |
---|
CAS Registry Number | 303-81-1 |
---|
SMILES | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C |
---|
InChI Identifier | InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 |
---|
InChI Key | YJQPYGGHQPGBLI-KGSXXDOSSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as coumarin glycosides. These are aromatic compounds containing a carbohydrate moiety glycosidically bound to a coumarin moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Coumarins and derivatives |
---|
Sub Class | Coumarin glycosides |
---|
Direct Parent | Coumarin glycosides |
---|
Alternative Parents | |
---|
Substituents | - Coumarin-7-o-glycoside
- Coumarin o-glycoside
- Phenolic glycoside
- 4-hydroxycoumarin
- Hydroxycoumarin
- Hexose monosaccharide
- O-glycosyl compound
- Glycosyl compound
- Benzopyran
- 1-benzopyran
- Benzamide
- Benzoic acid or derivatives
- Benzoyl
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Pyranone
- Pyran
- Monocyclic benzene moiety
- Monosaccharide
- Oxane
- Benzenoid
- Heteroaromatic compound
- Vinylogous acid
- Carbamic acid ester
- Carboxamide group
- Secondary carboxylic acid amide
- Secondary alcohol
- Lactone
- Carbonic acid derivative
- Ether
- Dialkyl ether
- Acetal
- Organoheterocyclic compound
- Carboxylic acid derivative
- Oxacycle
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0097 g/L | Not Available | LogP | 4.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Novobiocin,1TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4788.5 | Semi standard non polar | 33892256 | Novobiocin,1TMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4779.2 | Semi standard non polar | 33892256 | Novobiocin,1TMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4768.0 | Semi standard non polar | 33892256 | Novobiocin,1TMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4831.0 | Semi standard non polar | 33892256 | Novobiocin,1TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4620.3 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4693.2 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4752.0 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4559.4 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4680.6 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #3 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4757.0 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #4 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4532.4 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4700.3 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4744.8 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #7 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4499.7 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4737.4 | Semi standard non polar | 33892256 | Novobiocin,2TMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4503.7 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4643.0 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4706.0 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4506.8 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #12 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4689.7 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #13 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4510.9 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #14 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4511.6 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #2 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4698.4 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4446.9 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4695.7 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4450.0 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4696.2 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #7 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4527.4 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4708.2 | Semi standard non polar | 33892256 | Novobiocin,3TMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4465.4 | Semi standard non polar | 33892256 | Novobiocin,1TBDMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4976.1 | Semi standard non polar | 33892256 | Novobiocin,1TBDMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4968.9 | Semi standard non polar | 33892256 | Novobiocin,1TBDMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4970.2 | Semi standard non polar | 33892256 | Novobiocin,1TBDMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5047.5 | Semi standard non polar | 33892256 | Novobiocin,1TBDMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4836.2 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5057.9 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5197.9 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4964.1 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5060.9 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #3 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5109.2 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #4 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4914.0 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5089.2 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5123.1 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #7 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4899.7 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5125.7 | Semi standard non polar | 33892256 | Novobiocin,2TBDMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4919.9 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9501040000-ea711ce6f17080b821c2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (1 TMS) - 70eV, Positive | splash10-000i-9531007000-845ccc25b7b9a4ba819d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_11) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-03di-0000009000-b1cde524a6fa9a8469fb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-03di-0000449000-4b6598caa7dcff199d3c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0230-0005904000-5fe18777e8a9abd4250a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0a59-0096200000-4ea433cdc759c03b554d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0a4i-0091000000-912d33bd49e7c2686b5b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-03di-0141009000-46efbf9ab2bd123e3329 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-e321cd21925818d2156a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-6425ec6e8bbb44075cf4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-32fb8ff4ec7fde30b513 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-004f89ab3d920e8c5936 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000j-0933000000-cd71bb412108d603ba2d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 50V, Negative-QTOF | splash10-0a4i-0091000000-912d33bd49e7c2686b5b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Negative-QTOF | splash10-0a59-0096200000-4ea433cdc759c03b554d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-0a59-0096200000-11dbab50d0282c78d5d3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 50V, Positive-QTOF | splash10-000i-0900000000-7e8f1b6857305a58cdd6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin -1V, Positive-QTOF | splash10-000i-0900000000-fa445cda52f068430dd9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-000i-0900000000-659dbda5f820b7b4b5a9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 10V, Positive-QTOF | splash10-03di-0141009000-46efbf9ab2bd123e3329 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 30V, Positive-QTOF | splash10-000i-0900000000-ba6e55c3d22bd781820c | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 10V, Positive-QTOF | splash10-01ot-2319062000-88f8c273adda497b18db | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 20V, Positive-QTOF | splash10-000j-1619010000-8f36ccee24f46649d2fa | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-029i-4902000000-251ff87ab1779a3c93ee | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 10V, Negative-QTOF | splash10-0006-8092031000-b1e5ad67b96535763fdf | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 20V, Negative-QTOF | splash10-0006-9003030000-1010bbb42c15ce8156a5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 40V, Negative-QTOF | splash10-0006-9322000000-7884d3b71b2733b2e74f | 2016-08-03 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01051 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01051 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01051 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00002487 |
---|
Chemspider ID | 10226117 |
---|
KEGG Compound ID | C05080 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Novobiocin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 54675769 |
---|
PDB ID | NOV |
---|
ChEBI ID | 28368 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - DAVID NA, BURGNER PR: Clinical effectiveness and safety of novobiocin. Antibiotic Med Clin Ther (New York). 1956 Apr;2(4):219-29. [PubMed:13303117 ]
- CORBIN EE, PRIGOT A: Novobiocin; absorption, diffusion, and excretion studies. Antibiot Annu. 1956-1957:392-5. [PubMed:13425410 ]
- Singh G, Jayanarayan KG, Dey CS: Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani. Mol Biochem Parasitol. 2005 May;141(1):57-69. [PubMed:15811527 ]
- Burlison JA, Neckers L, Smith AB, Maxwell A, Blagg BS: Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. J Am Chem Soc. 2006 Dec 6;128(48):15529-36. [PubMed:17132020 ]
- Vickers AA, Chopra I, O'Neill AJ: Intrinsic novobiocin resistance in Staphylococcus saprophyticus. Antimicrob Agents Chemother. 2007 Dec;51(12):4484-5. Epub 2007 Sep 17. [PubMed:17876001 ]
|
---|